Post-cesarean Opioid Consumption in Patients on Maintenance Medication for Opioid Use Disorder Undergoing Cesarean Delivery With Neuraxial Anesthesia: A Single-Center Retrospective Propensity Matched Cohort Study (2016–2020)

( Int J Obstet Anesth . 2025:64:104742. doi:10.1016/j.ijoa.2025.104742) Opioid use disorder (OUD) is a major global health concern, with increasing prevalence among pregnant individuals and substantial associated maternal morbidity and mortality. Pharmacologic maintenance therapy with methadone or buprenorphine is widely recommended during pregnancy and the postpartum period because it improves maternal outcomes and reduces mortality. However, effective postoperative pain management after cesarean delivery (CD) in patients receiving medications for opioid use disorder (MOUD) presents ongoing clinical challenges. These patients often report greater pain intensity and require higher doses of supplemental opioids compared with opioid-naive individuals. Existing studies evaluating post-CD opioid consumption in this population have produced inconsistent findings, largely due to variability in anesthetic techniques and inconsistent use of neuraxial opioids and multimodal analgesia.

Authors

Publication Details

Journal
Obstetric Anesthesia Digest
Published
2026-11-18
DOI
https://doi.org/10.1097/01.aoa.0001289080.29031.1a
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Post-cesarean Opioid Consumption in Patients on Maintenance Medication for Opioid Use Disorder Undergoing Cesarean Delivery With Neuraxial Anesthesia: A Single-Center Retrospective Propensity Matched Cohort Study (2016–2020)

A Mongan, L Chitty, P Mongan, M Kotova et al.
Obstetric Anesthesia Digest
Anesthesia and Pain Management
article

Post-cesarean Opioid Consumption in Patients on Maintenance Medication for Opioid Use Disorder Undergoing Cesarean Delivery With Neuraxial Anesthesia: A Single-Center Retrospective Propensity Matched Cohort Study (2016–2020)

A Mongan, L Chitty, P Mongan, M Kotova, C Ripat, B Johnson, S Roy
article en

Abstract

( Int J Obstet Anesth . 2025:64:104742. doi:10.1016/j.ijoa.2025.104742) Opioid use disorder (OUD) is a major global health concern, with increasing prevalence among pregnant individuals and substantial associated maternal morbidity and mortality. Pharmacologic maintenance therapy with methadone or buprenorphine is widely recommended during pregnancy and the postpartum period because it improves maternal outcomes and reduces mortality. However, effective postoperative pain management after cesarean delivery (CD) in patients receiving medications for opioid use disorder (MOUD) presents ongoing clinical challenges. These patients often report greater pain intensity and require higher doses of supplemental opioids compared with opioid-naive individuals. Existing studies evaluating post-CD opioid consumption in this population have produced inconsistent findings, largely due to variability in anesthetic techniques and inconsistent use of neuraxial opioids and multimodal analgesia.

Obstetric Anesthesia DigestVol. 46(4)
Good health and well-being
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon